Skip to Content

KU 7 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint KU 7 is Blue, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Kremers Urban Pharmaceuticals Inc..

Rabeprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 7

Rabeprazole sodium delayed-release 20 mg KU 7
Rabeprazole sodium delayed-release 20 mg KU 7
Rabeprazole sodium delayed-release 20 mg KU 7

Rabeprazole Sodium Delayed-Release

Imprint:
KU 7
Strength:
20 mg
Color:
Blue
Shape:
Round
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Kremers Urban Pharmaceuticals Inc.
National Drug Code (NDC):
62175-0302

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide